1 – 10 of 29
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Transforming spinal surgery with innovations in biologics and additive manufacturing
    
    
- Contribution to journal › Scientific review
 
 - 2024
 - 
                        Mark
        Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
    
    
- Contribution to journal › Article
 
 - 2023
 - 
                        Mark
        Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis : A Decision Tree Analysis by Indication
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Eosinophils—from cradle to grave
    
    
- Contribution to journal › Article
 
 
